US Patent Issued to GRUENENTHAL on Sept. 29 for "Substituted [1,2,4triazolo[4,3-aquinoxalines, dosage forms containing them, and methods of using them to treat or prevent pain and/or inflammation" (German, Belgian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,240, issued on Sept. 29, was assigned to GRUENENTHAL GMBH (Germany).

"Substituted [1,2,4triazolo[4,3-aquinoxalines, dosage forms containing them, and methods of using them to treat or prevent pain and/or inflammation" was invented by Jo Alen (Averbode, Belgium), Florian Jakob (Aachen, Germany), Sebastian Krueger (Aachen, Germany), Daniela Friebe (Duesseldorf, Germany) and Stephanie Hennen (Aachen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds according to general formula (I)which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which...